Obesity

Effects of Weight‐Loss Interventions on Kidney, Cardiometabolic and Anthropometric Outcomes in Adults With Chronic Kidney Disease (CKD) and Overweight or Obesity: A Systematic Review and Meta‐Analysis

Diabetes Obes MetabPublished Systematic review and meta-analysis of randomised trials

Authors' conclusion

In CKD patients with overweight or obesity, all types of interventions (lifestyle, pharmacological, surgical) are effective for weight-loss. Incretin-based therapies confer additional nephroprotective effects by significantly reducing albuminuria.

Study context

Population
Overweight or obese adults with any stage of CKD; searches of PubMed, CENTRAL and Embase up to August 2025
Participants
11,017 participants42 studies
Comparison
Weight-loss interventions vs control
Outcome
Kidney and cardiovascular outcomes and mortality
Methodological detailsupdated
  • Updated

Pooled result

As reported in the abstract

Kidney, cardiovascular outcomes and mortality
Each group vs placeboMD, mL/min/1.73 m2 (95% CI)
Bariatric surgeryeGFR; I 2 = 1%
6.09(3.66–8.52)
Pharmacological · I 2 = 86%
reduction in urine albumin-to-creatinine ratio 41% (95% CI 29%–52%)

Further pooled results

OutcomeMD (kg) (95% CI)
Weight loss (anthropometric parameters)Lifestylevs PlaceboI 2 = 83%−4.13 (−6.49 to −1.76)
OutcomeMD (mm Hg) (95% CI)
SBPLifestylevs PlaceboI 2 = 45%−3.10 (−7.59 to 1.38)

Weight loss (anthropometric parameters)

Weight, BMI and waist circumference improved across all intervention categories

SBP

Systolic and diastolic blood pressure (BP) showed modest, non-significant reductions following lifestyle interventions; data for pharmacological and surgical approaches were limited

Original publication

Effects of Weight‐Loss Interventions on Kidney, Cardiometabolic and Anthropometric Outcomes in Adults With CKD and Overweight or Obesity: A Systematic Review and Meta‐Analysis. Diabetes Obes Metab. Published 22 June 2026. doi:10.1111/dom.70997

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.